MERCK Kommanditgesellschaft auf Aktien (MKGAF)
MKGAF Stock Price Chart
Explore MERCK Kommanditgesellschaft auf Aktien interactive price chart. Choose custom timeframes to analyze MKGAF price movements and trends.
MKGAF Company Profile
Discover essential business fundamentals and corporate details for MERCK Kommanditgesellschaft auf Aktien (MKGAF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
3 Aug 2012
Employees
59.02K
Website
https://www.merckgroup.comCEO
Belen Garijo Lopez
Description
MERCK Kommanditgesellschaft auf Aktien operates in the healthcare, life science, and electronics sectors worldwide. It discovers, develops, manufactures, and markets pharmaceutical and biological prescription drugs to treat neurology and immunology, oncology, fertility, and cardiology metabolism and endocrinology. The company also supplies products, tools, and services for research laboratories, pharma and biotech production, and industrial and testing laboratories. In addition, it offers material for integrated circuits, liquid crystals, organic light-emitting diodes, photoresists, smart antenna, and liquid crystal glazing solutions, as well as effect pigments for use in automotive coatings, cosmetics, industrial, and plastic applications. It has strategic alliances with Pfizer Inc.; agreement with Novartis AG; and license agreements with Debiopharm International SA and MoonLake Immunotherapeutics AG. The company was founded in 1668 and is headquartered in Darmstadt, Germany. MERCK Kommanditgesellschaft auf Aktien is a subsidiary of E. Merck Kommanditgesellschaft.
MKGAF Financial Timeline
Browse a chronological timeline of MERCK Kommanditgesellschaft auf Aktien corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 13 May 2026
Upcoming earnings on 4 Mar 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 7 Aug 2025
EPS came in at $1.77 falling short of the estimated $2.52 by -29.76%, while revenue for the quarter reached $6.19B , beating expectations by +0.71%.
Earnings released on 12 May 2025
EPS came in at $1.85 falling short of the estimated $2.34 by -20.94%, while revenue for the quarter reached $5.79B , missing expectations by -3.00%.
Earnings released on 6 Mar 2025
EPS came in at $1.59 falling short of the estimated $2.23 by -28.70%, while revenue for the quarter reached $5.61B , missing expectations by -2.53%.
Dividend declared on 3 Feb 2025
A dividend of $2.51 per share was announced, adjusted to $2.50. The dividend was paid on 30 Apr 2025.
Earnings released on 14 Nov 2024
EPS came in at $2.56 surpassing the estimated $2.52 by +1.59%, while revenue for the quarter reached $21.91B , beating expectations by +269.24%.
Earnings released on 1 Aug 2024
EPS came in at $1.51 falling short of the estimated $2.20 by -31.36%, while revenue for the quarter reached $5.75B , beating expectations by +1.43%.
Earnings released on 15 May 2024
EPS came in at $1.74 falling short of the estimated $1.92 by -9.37%, while revenue for the quarter reached $5.50B , missing expectations by -0.24%.
Earnings released on 7 Mar 2024
EPS came in at $1.99 falling short of the estimated $2.15 by -7.44%, while revenue for the quarter reached $5.75B , missing expectations by -0.78%.
Dividend declared on 2 Feb 2024
A dividend of $2.36 per share was announced, adjusted to $2.35. The dividend was paid on 2 May 2024.
Earnings released on 9 Nov 2023
EPS came in at $1.85 falling short of the estimated $2.09 by -11.48%, while revenue for the quarter reached $5.46B , missing expectations by -0.98%.
Earnings released on 3 Aug 2023
EPS came in at $2.40 surpassing the estimated $2.39 by +0.42%, while revenue for the quarter reached $5.78B , beating expectations by +1.22%.
Earnings released on 10 May 2023
EPS came in at $1.96 falling short of the estimated $2.50 by -21.60%, while revenue for the quarter reached $5.75B , beating expectations by +0.13%.
Dividend declared on 7 Mar 2023
A dividend of $2.42 per share was announced, adjusted to $2.42. The dividend was paid on 4 May 2023.
Earnings released on 2 Mar 2023
EPS came in at $2.47 falling short of the estimated $2.61 by -5.36%, while revenue for the quarter reached $6.10B , missing expectations by -0.40%.
Earnings released on 9 Nov 2022
EPS came in at $2.70 matching the estimated $2.70, while revenue for the quarter reached $5.67B , beating expectations by +1.49%.
Earnings released on 4 Aug 2022
EPS came in at $2.69 surpassing the estimated $2.59 by +3.86%, while revenue for the quarter reached $5.82B , beating expectations by +2.59%.
Earnings released on 12 May 2022
EPS came in at $2.52 surpassing the estimated $2.47 by +2.02%, while revenue for the quarter reached $5.75B , beating expectations by +2.05%.
Dividend declared on 4 Mar 2022
A dividend of $1.98 per share was announced, adjusted to $2.00. The dividend was paid on 27 Apr 2022.
Earnings released on 3 Mar 2022
EPS came in at $2.27 falling short of the estimated $2.33 by -2.58%, while revenue for the quarter reached $5.91B , beating expectations by +0.65%.
Earnings released on 11 Nov 2021
EPS came in at $2.57 matching the estimated $2.57, while revenue for the quarter reached $5.77B .
Earnings released on 5 Aug 2021
EPS came in at $2.70 , while revenue for the quarter reached $5.78B .
Earnings released on 12 May 2021
EPS came in at $2.63 surpassing the estimated $1.74 by +51.15%, while revenue for the quarter reached $5.45B .
Earnings released on 4 Mar 2021
EPS came in at $1.87 , while revenue for the quarter reached $5.64B .
Dividend declared on 4 Mar 2021
A dividend of $1.69 per share was announced, adjusted to $1.69. The dividend was paid on 28 Apr 2021.
Earnings released on 11 Nov 2020
EPS came in at $2.76 surpassing the estimated $2.62 by +5.34%, while revenue for the quarter reached $5.22B .
MKGAF Stock Performance
Access detailed MKGAF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.